TrialThe international journal of neuropsychopharmacology2026

Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study.

Christine Pinter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.